Priming of polymorphonuclear leukocytes: A culprit in the initiation of endothelial cell injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 5, 2006, Pages

  Jacobi, Jeanna ^a   Sela, Shifra ^a,b   Cohen, Hector I ^a   Chezar, Judith ^a   Kristal, Batya ^a,b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cocultivation; Nicotinamide adenine dinucleotide phosphate oxidase; Polymorphonuclear leukocyte priming index

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; PADGEM PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MORPHOLOGY; NEUTROPHIL; PRIORITY JOURNAL;

CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS;

EID: 33646401509     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01040.2005     Document Type: Article

References (49)

1. -/- mice. J Clin Invest 108: 1513-1522, 2001.
2. Carre PC, Mortenson RL, King TE, Noble PW, Sable CL, and Riches DW. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 88: 1802-1810, 1991.
3. Cascone MG, Tricoli M, Cerrai P, and Sbarbati-Del-Guerra R. Cell cultures in the biocompatibility study of synthetic materials. Cytotechnology 11, Suppl 1: S137-S139, 1993.
4. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB, Pastorino AM, and Lo Cascio V. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med 22: 117-127, 1997.
5. DeLoughery TG and Goodnight SH. The hypercoagulable states: diagnosis and management. Semin Vasc Surg 6: 66-74, 1993.
6. Dhalla NS, Elmoselhi AB, Hata T, and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47: 446-456, 2000.
7. Diaz C, Valverde L, Brenes O, Rucavado A, and Gutierrez JM. Characterization of events associated with apoptosis/anoikis induced by snake venom metalloproteinase BaP1 on human endothelial cells. J Cell Biochem 94: 520-528, 2005.
8. Engel CJ, Bennett ST, Chambers AF, Doig GS, Kerkvliet N, and O'Malley FP. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 20: 1260-1265, 1996.
9. Erlinger TP, Tarver-Carr ME, Powe NR, Appel LJ, Coresh J, Eberhardt MS, and Brancati FL. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis 42: 256-263, 2003.
10. Galle J, Heermeier K, and Wanner C. Atherogenic lipoproteins, oxidative stress, and cell death. Kidney Int, Suppl 71: S62-S65, 1999.
11. Galle J, Schneider R, Heinloth A, Wanner C, Galle PR, Conzelmann E, Dimmeler S, and Heermeier K. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney Int 55: 1450-1461, 1999.
12. Ghosh S, Gepstein S, Heikkila JJ, and Dumbroff EB. Use of a scanning densitometer or an ELISA plate reader for measurement of nanogram amounts of protein in crude extracts from biological tissues. Anal Biochem 169: 227-233, 1988.
13. Goligorsky MS. Endothelial cell dysfunction: can't live with it, how to live without it. Am J Physiol Renal Physiol 288: F871-F880, 2005.
14. Haag-Weber M and Horl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 16: 192-201, 1996.
15. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, and Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119: 101-110, 1985.
16. Hayward R and Lefer AM. Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion. Am J Physiol Heart Circ Physiol 275: H2080-H2086, 1998.
17. Ishii Y, Yano S, Kanai H, Maezawa A, Tsuchida A, Wakamatsu R, and Naruse T. Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis. Nephron 73: 407-412, 1996.
18. Jacobi J, Kristal B, Chezar J, Shasha S, and Sela S. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med 39: 1238-1248, 2005.
19. Jaffe EA, Nachman RL, Becker CG, and Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756, 1973.
20. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, and Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267: 14519-14522, 1992.
21. Karakurum M, Shreeniwas R, Chen J, Pinsky D, Yan SD, Anderson M, Sunouchi K, Major J, Hamilton T, and Kuwabara K. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 93: 1564-1570, 1994.
22. Klebanoff SJ and Clark RA. Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med 89: 675-686, 1977.
23. Krishnaswamy G, Kelley J, Yerra L, Smith JK, and Chi DS. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19: 91-104, 1999.
24. Kristal B, Shurtz-Swirski R, Chezar J, Manaster J, Levy R, Shapiro G, Weissman I, Shasha SM, and Sela S. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 11: 921-928, 1998.
25. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, and Lubin BH. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 87: 1179-1187, 1996.
26. 2 and tumor necrosis factor-α induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 273: 32670-32678, 1998.
27. Lanir N, Zilberman M, Yron I, Tennenbaum G, Shechter Y, and Brenner B. Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration. J Lab Clin Med 131: 548-556, 1998.
28. Li AE, Ito H, Rovira II, Kim KS, Takeda K, Yu ZY, Ferrans VJ, and Finkel T. A role for reactive oxygen species in endothelial cell anoikis. Circ Res 85: 304-310, 1999.
29. Li H, Junk P, Huwiler A, Burkhardt C, Wallerath T, Pfeilschifter J, and Forstermann U. Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation 106: 2250-2256, 2002.
30. Li JM and Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14, Suppl 3: S221-S226, 2003.
31. Mercier E, Branger B, Vecina F, Al-Sabadani B, Berlan J, Dauzat M, Fourcade J, and Gris JC. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency. Hematol J 2: 18-25, 2001.
32. Peterson TE, Poppa V, Ueba H, Wu A, Yan C, and Berk BC. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res 85: 29-37, 1999.
33. Rosenfeld ME. Inflammation, lipids, and free radicals: lessons learned from the atherogenic process. Semin Reprod Endocrinol 16: 249-261, 1998.
34. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138: S419-S420, 1999.
35. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
36. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, and Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14: 1521-1528, 1994.
37. Segarra A, Chacon P, Martinez-Eyarre C, Argelaguer X, Vila J, Ruiz P, Fort J, Bartolome J, Camps J, Moliner E, Pelegri A, Marco F, Olmos A, and Piera L. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol 12: 1255-1263, 2001.
38. Sela S, Shurtz-Swirski R, Awad J, Shapiro G, Nasser L, Shasha SM, and Kristal B. The involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in cigarette smokers. Isr Med Assoc J 4: 1015-1019, 2002.
39. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, and Kristal B. The primed peripheral polymorphonuclear leukocyte - a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 16: 2431-2438, 2005.
40. Sengoelge G, Fodinger M, Skoupy S, Ferrara I, Zangerle C, Rogy M, Horl WH, Sunder-Plassmann G, and Menzel J. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGEmodified fibronectin. Kidney Int 54: 1637-1651, 1998.
41. Shurtz-Swirski R, Sela S, Shapiro G, Nasser L, Shasha SM, and Kristal B. Involvement of polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetes. Diabetes Care 24: 104-110, 2001.
42. Stenvinkel P. Endothelial dysfunction and inflammation - is there a link? Nephrol Dial Transplant 16: 1968-1971, 2001.
43. Swain SD, Rohn TT, and Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal 4: 69-83, 2002.
44. Taekema-Roelvink ME, Van Kooten C, Heemskerk E, Schroeijers W, and Daha MR. Proteinase 3 interacts with a 111-kD membrane molecule of human umbilical vein endothelial cells. J Am Soc Nephrol 11: 640-648, 2000.
45. Tomita M and Fukuuchi Y. Leukocytes, macrophages and secondary brain damage following cerebral ischemia. Acta Neurochir Suppl (Wien) 66: 32-39, 1996.
46. Villanueva ME, Zaher FM, Svinarich DM, and Konduri GG. Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 44: 338-343, 1998.
47. Weyrich AS, Buerke M, Albertine KH, and Lefer AM. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol 57: 45-55, 1995.
48. Yoshizumi M, Perrella MA, Burnett JC Jr, and Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73: 205-209, 1993.
49. Zhang DX, Zou AP, and Li PL. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am J Physiol Heart Circ Physiol 284: H605-H612, 2003.